8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

CME Group filed Form 8‑K (Item 9.01) on Feb 2, 2026 — Exhibit 104: Inline XBRL cover page submitted.

Filed with the SEC on February 2, 2026 · Summarized by InvestorsBot

CME Group filed Form 8‑K (Item 9.01) on Feb 2, 2026 — Exhibit 104: Inline XBRL cover page submitted. Signed by Lynne Fitzpatrick, Senior Managing Director, President & CFO. 📄 $CME #SEC #XBRL

Filing contains no financial statements or material business disclosures — appears administrative to meet XBRL/filing requirements. Investors: no operational or financial change disclosed. ✅ $CME #8K #Compliance

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from CME GROUP INC.

CME Group files 8-K furnishing July 22 press release

8-K · July 22, 2026

CME Group reports second-quarter 2026 financial results

8-K · July 22, 2026

$CME filed a Form 8‑K on Feb 4, 2026 furnishing a press release (Exhibit 99.1) and an Inline XBRL cover…

8-K · February 4, 2026

CME Group attached a press release (Exhibit 99.1) dated Feb 4, 2026 reporting financial results for the…

8-K · February 4, 2026

CME Group ($CME) on Feb 2, 2026 communicated pricing changes to clients via Special Executive Report 9676;…

8-K · February 2, 2026